Announcements Trials
Browse Landscape

Phase

Phase 1 16Phase 2 14Phase 1/2 5Phase EARLY_PHASE1 3Phase NA 2Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 26Leukemia, Lymphocytic, Chronic, B-Cell 16Myelodysplastic Syndromes 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 6Lymphoma, Follicular 6Leukemia 6Multiple Myeloma 5Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Recurrence 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Graft vs Host Disease 2Waldenstrom Macroglobulinemia 1Venentoclax 1Sarcoma, Synovial 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm, Residual 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Biphenotypic, Acute 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

Cyclophosphamide 24Vincristine 19Doxorubicin 17Radiotherapy 14Prednisone 13Methotrexate 13Cytarabine 13Rituximab 11Dexamethasone 11pegaspargase 10Filgrastim 10Etoposide 10Mercaptopurine 9Calcium Dobesilate 9merphos 8dexamethasone acetate 8dexamethasone 21-phosphate 8azathiopurine 8auricularum 8Thioguanine 8Leucovorin 8Radiation 7Daunorubicin 7prednylidene 6deltacortene 6Asparaginase 6blinatumomab 5Prednisolone 5Peripheral Blood Stem Cell Transplantation 5calaspargase pegol 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Burkitt Lymphoma × fludarabine × Clear all
NCT07223021 2026-06-04

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting
130 enrolled
Lymphoid

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡